|
1
|
McErlean C, Gonzalez AA, Cunningham R,
Meenagh A, Shovlin T and Middleton D: Differential RNA expression
of KIR alleles. Immunogenetics. 62:431–440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao X, Hou L, Sun A, Chen M, Chen Z and He
J: An allelic typing method for 2DS4 variant used in study of
haplotypes of killer cell immunoglobulin-like receptor gene. Int J
Lab Hematol. 32(6p2): 625–632. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhuang YL, Zhu CF, Zhang Y, Song YH, Wang
DJ, Nie XM, Liu Y and Ren GJ: Association of KIR2DS4 and its
variant KIR1D with syphilis in a Chinese Han population. Int J
Immunogenet. 39:114–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salim PH, Jobim M, Jobim LF and Xavier RM:
Autoimmune rheumatic diseases and their association with killer
immunoglobulin-like receptor genes. Rev Bras Reumatol. 51:351–356,
362-364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mosaad YM, Mansour M, Al-Muzairai I,
Al-Otabi T, Abdul-Moneam M, Al-Attiyah R and Shahin M: Association
between human leukocyte antigens (HLA-A, -B, and -DR) and end-stage
renal disease in Kuwaiti patients awaiting transplantation. Ren
Fail. 36:1317–1321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weitkamp LR, Moss AJ, Lewis RA, Hall WJ,
MacCluer JW, Schwartz PJ, Locati EH, Tzivoni D, Vincent GM,
Robinson JL, et al: Analysis of HLA and disease susceptibility:
chromosome 6 genes and sex influence long-QT phenotype. Am J Hum
Genet. 55:1230–1241. 1994.PubMed/NCBI
|
|
7
|
Ben Hamad M, Mahfoudh N, Marzouk S,
Kammoun A, Gaddour L, Hakim F, Fakhfakh F, Bahloul Z, Makni H and
Maalej A: Association study of human leukocyte antigen-DRB1 alleles
with rheumatoid arthritis in south Tunisian patients. Clin
Rheumatol. 31:937–942. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karahan GE, Kekik C, Oguz FS, Onal AE,
Bakkaloğlu H, Calişkan YK, Yazici H, Turkmen A, Aydin AE, Sever MS,
et al: Association of HLA phenotypes of end-stage renal disease
patients preparing for first transplantation with anti-HLA antibody
status. Ren Fail. 32:380–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiyun Y, Guisen L, Li Z, Yi S, Jicheng L,
Fang L, Xiaoqi L, Shi M, Cheng J, Ying L, et al: The genetic
variants at the HLA-DRB1 gene are associated with primary IgA
nephropathy in Han Chinese. BMC Med Genet. 13:332012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao X, Liu L, Li WJ, Liu J and Chen DJ:
HLA-A, HLA-B, HLA-DRB1 polymorphisms and risk of cervical squamous
epithelial cell carcinoma: a population study in China. Asian Pac J
Cancer Prev. 14:4427–4433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amirzargar AA, Yalda A, Hajabolbaghi M,
Khosravi F, Jabbari H, Rezaei N, Niknam MH, Ansari B, Moradi B and
Nikbin B: The association of HLA-DRB, DQA1, DQB1 alleles and
haplotype frequency in Iranian patients with pulmonary
tuberculosis. Int J Tuberc Lung Dis. 8:1017–1021. 2004.PubMed/NCBI
|
|
12
|
Franco C, Yoo W, Franco D and Xu Z:
Predictors of end stage renal disease in African Americans with
lupus nephritis. Bull NYU Hosp Jt Dis. 68:251–256. 2010.PubMed/NCBI
|
|
13
|
El-Gezawy EM, Baset HA, Nasif KA, Osama A,
AbdelAzeem HG, Ali M and Khalil RY: Human leukocyte antigens as a
risk factor for the primary diseases leading to end stage renal
disease in Egyptian patients. Egypt J Immunol. 18:13–21.
2011.PubMed/NCBI
|
|
14
|
Korva M, Saksida A, Kunilo S, Jeras B
Vidan and Avsic-Zupanc T: HLA-associated hemorrhagic fever with
renal syndrome disease progression in slovenian patients. Clin
Vaccine Immunol. 18:1435–1440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Catamo E, Zupin L, Crovella S, Celsi F and
Segat L: Non-classical MHC-I human leukocyte antigen (HLA-G) in
hepatotropic viral infections and in hepatocellular carcinoma. Hum
Immunol. 75:1225–1231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X, Jia J, Dong J, Yu F, Ma N, Li M,
Liu X, Liu W, Li T and Liu D: HLA-DQ polymorphisms with HBV
infection: different outcomes upon infection and prognosis to
lamivudine therapy. J Viral Hepat. 21:491–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pollicino T, Cacciola I, Saffioti F and
Raimondo G: Hepatitis B virus PreS/S gene variants: pathobiology
and clinical implications. J Hepatol. 61:408–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH,
Lee HS, Kim CY, Cheong JY, Cho SW, Park NH, et al: A genome-wide
association study identified new variants associated with the risk
of chronic hepatitis B. Hum Mol Genet. 22:4233–4238. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du
Y, Pu R, Han Y, Zhao J, Han X, et al: HLA-DP polymorphisms affect
the outcomes of chronic hepatitis B virus infections, possibly
through interacting with viral mutations. J Virol. 87:12176–12186.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mansouri L, Messalmani M, Klai S, Bedoui
I, Derbali H, Gritli N, Mrissa R and Fekih-Mrissa N: Association of
HLA-DR/DQ polymorphism with Alzheimer's disease. Am J Med Sci.
349:334–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
